• AAPL 182.53
  • TSLA 185.5017
  • AMZN 185.55
  • MSFT 407.6
  • INTC 31.125
  • EURUSD 1.079
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. CO /
  3. BAVA.CO

Bavarian Nordic (BAVA CO) stock market data APIs

kr151.46 -4.14(-2.7%) as of May 3, 2024

Bavarian Nordic Financial Data Overview

155.28
151.46
-
158.54
151.86
125.55-222
12 128 M
8.1042
77 944 K
7 062 M
1.33
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BAVA',
Type: 'Common Stock',
Name: 'Bavarian Nordic',
Exchange: 'CO',
CurrencyCode: 'DKK',
CurrencyName: 'Danish krone',
CurrencySymbol: 'kr',
CountryName: 'Denmark',
CountryISO: 'DK',
OpenFigi: NULL,
ISIN: 'DK0015998017',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Bavarian Nordic Fundamental Data is available in our Financial Data APIs

  • Net Revenue 7 062 M
  • EBITDA 2 685 M
  • Earnings Per Share 19.2
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bavarian Nordic Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast 1.9

Get Bavarian Nordic End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bavarian Nordic latest news via APIs

Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve

Bavarian Nordic A/S COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to...

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

Bavarian Nordic A/S COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administra...
Do you have any questions?
support@eodhistoricaldata.com